ACTRN12611000613909招募中未知
A prospective study of antimullerian hormone (AMH) as a potential predictor of chemotherapy induced menopause in premenopausal women age 18-45 undergoing curative intent chemotherapy
Hilary Martin0 个研究点目标入组 20 人开始时间: 2011年6月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •*Female planned for first line gonadotoxic chemotherapy defined as chemotherapy associated with >25% rates of ovarian failure. Examples of appropriate chemotherapy regimens includes: FAC, FEC, AC, AC-T, , FEC-D, TAC, TC, R-CHOP, ABVD and BEACOPP
- •* Cancer treated with curative intent
- •* Age 18-45
- •* Premenopausal defined as at least 2 menstrual cycles within 180 days of study enrolment or if recently ceased oral or implantable contraception gonadotropin levels within premenopausal range
- •* Able to provide informed consent
排除标准
- •* planned for long term GNRH analogue post chemotherapy
- •* hysterectomy and/or bilateral oophorectomy prior to commencement of chemotherapy
- •* pregnant at time of enrolment
研究者
相似试验
已完成
不适用
Evaluating the effect of metformine on antimullerian hormone(AMH ) in polycystic ovarian syndrome –a clinical trialPolycystic ovarian syndrome.IRCT2014081918858N1Diabet Research Center, Yazd Shahid Sadoughi Univercity Of Medical Science42
已完成
不适用
Evaluation blood level of anti-m?llerian hormone measurement efficiency in prediction of the response to weight loss diet in obese women with polycystic ovarian syndrome with infertility problem.Obesity in polycystic ovary syndrome women.Polycystic ovarian syndromeIRCT201302241141N14Royan institute80
尚未招募
不适用
The relartionship of serum Antimullerian Hormone and arteriosclerosis in women with Polycystic Ovarian Syndrome.Polysistic ovaryJPRN-UMIN000027426Department of Obstetrics and Gynecology Okayama University Graduate School of Medicine, Density and Pharmaceutical Sciences.60
已完成
不适用
Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years OldAMH LevelsInhibin B LevelsIVF Patients Over 38 Years OldNCT01219387Reproductive Medicine Associates of New Jersey300
已完成
2 期
Evaluation of the changes of hormone in polycystic ovarian syndrome, following ovarian drillingIRCT20141230020486N4Mashhad University of Medical Sciences30